Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6074222 | Journal of Dermatological Science | 2015 | 10 Pages |
Abstract
DHE-Glc improved AD-like skin inflammatory symptoms on the backs of DNCB-induced mice, partly by suppressing production of Th2 chemokines, CCL17 and CCL22 in inflamed skin. Therefore, DHE-Glc is a potential therapeutic agent for skin inflammatory diseases such as AD.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Mira Jung, Tae Hoon Lee, Hyun Jeoung Oh, Hakwon Kim, Youngsook Son, Eunjoo H. Lee, Jiyoung Kim,